APA (7th ed.) Citation

NJ, N., PY, F., MS, K., I, M., DP, M., K, S., . . . P, T. (2026). Glucocorticoid reduction after starting crinecerfont in pediatric patients with classic congenital adrenal hyperplasia: Practical perspectives. The Journal of clinical endocrinology and metabolism, 111(8), e1937. https://doi.org/10.1210/clinem/dgag192

Chicago Style (17th ed.) Citation

NJ, Nokoff, Fechner PY, Kim MS, Marshall I, Merke DP, Sarafoglou K, Hartzell AL, Lin VH, and Thornton P. "Glucocorticoid Reduction After Starting Crinecerfont in Pediatric Patients with Classic Congenital Adrenal Hyperplasia: Practical Perspectives." The Journal of Clinical Endocrinology and Metabolism 111, no. 8 (2026): e1937. https://doi.org/10.1210/clinem/dgag192.

MLA (9th ed.) Citation

NJ, Nokoff, et al. "Glucocorticoid Reduction After Starting Crinecerfont in Pediatric Patients with Classic Congenital Adrenal Hyperplasia: Practical Perspectives." The Journal of Clinical Endocrinology and Metabolism, vol. 111, no. 8, 2026, p. e1937, https://doi.org/10.1210/clinem/dgag192.